Evidence map›Paper›PMID 32558172›Full record

ArticleDermatologic therapy2020

SARS-CoV-2 as possible inducer of viral reactivations.

Giulia Ciccarese, Aurora Parodi, Francesco Drago

Abstract readLetterComment
In one paragraph

Article in Dermatologic therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Oral lesions and saliva alterations of COVID-19 patients in an intensive care unit: A retrospective study.Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry · 2022
    Article
  8. Epstein-Barr virus and COVID-19.Journal of medical virology · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021
    Article
  17. Article
  18. Pityriasis rosea and COVID-19.Journal of medical virology · 2021
    Article
  19. Article
  20. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Giulia CiccareseDermatology Clinic, Ospedale Policlinico San Martino, Largo Rosanna Benzi, Genoa, Italy.ORCID 0000-0001-8363-0195
Aurora ParodiDermatology Clinic, Ospedale Policlinico San Martino, Largo Rosanna Benzi, Genoa, Italy.
Francesco DragoDermatology Clinic, Ospedale Policlinico San Martino, Largo Rosanna Benzi, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Herpesvirus 6, HumanMucocutaneous Lymph Node SyndromePityriasis RoseaHumansPandemicsSARS-CoV-2

Identifiers

PMID32558172
PMCPMC7323010

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.